HealthInvest Partners’s Boston Scientific BSX Stock Holding History

HealthInvest Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25M	Buy	146,381 +105,949	+262%	+$5.75M	1.68%	25
2026 Q1	$8.84M	Sell	40,432 -68,250	-63%	-$5.46M	2.86%	15
2025 Q4	$10.4M	Buy	108,682 +22,002	+25%	+$2.16M	3.31%	10
2025 Q3	$898K	Sell	86,680 -39,505	-31%	-$4.09M	3.33%	11
2025 Q2	$13.6M	Sell	126,185 -6,088	-5%	-$616K	5.8%	3
2025 Q1	$13.3M	Sell	132,273 -21,949	-14%	-$2.21M	5.89%	4
2024 Q4	$13.8M	Buy	154,222 +48,050	+45%	+$4.23M	6.56%	4
2024 Q3	$8.9M	Sell	106,172 -385	-0.4%	-$30.3K	4.18%	6
2024 Q2	$8.21M	Buy	106,557 +29,156	+38%	+$2.13M	5%	6
2024 Q1	$5.3M	Buy	77,401 +12,595	+19%	+$810K	3.23%	10
2023 Q4	$3.75M	Buy	+64,806	New	+$3.46M	2.93%	16
2022 Q4	$49.1K	Buy	+1,061	New	+$45.9K	0.09%	20

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HealthInvest Partners's BSX Position: Q2 2026 in Review

HealthInvest Partners increased its Boston Scientific (BSX) stake by 262% in Q2 2026, buying an estimated $5.75M and bringing the position to 146,381 shares worth $6.25M. The position accounts for 1.68% of the portfolio, ranked #25.

HealthInvest Partners first reported a position in BSX in Q4 2022 and has held it in 12 quarters since. The position peaked at $13.8M in Q4 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

HealthInvest Partners held 146,381 shares of Boston Scientific worth $6.25M as of Q2 2026.
HealthInvest Partners bought 105,949 Boston Scientific shares in Q2 2026, an estimated $5.75M.
Boston Scientific made up 1.68% of HealthInvest Partners's portfolio in Q2 2026, its #25 holding.
HealthInvest Partners first reported a position in Boston Scientific in Q4 2022 and has held it in 12 quarters since.
HealthInvest Partners's Boston Scientific position peaked at $13.8M in Q4 2024.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.